Sean Maduck Corcept Therapeutics Inc (CORT) insider trading activity

Sean Maduck is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 17,705 shares of CORT, which is worth approximately $1.26 Million. The most recent transaction as insider was on Oct 06, 2023, when has been sold 3,498 shares (Common Stock) at a price of $27.24 per share, resulting in proceeds of $95,285. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K

79.32% 3M change

79.02% 12M change

Total Value Held $1.26 Million

Sean Maduck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 06 2023	SELL Open market or private sale	$95,285 $27.24 p/Share	3,498 Reduced 4.54%	73,610 Common Stock
Oct 06 2023	BUY Exercise of conversion of derivative security	$10,563 $3.02 p/Share	3,498 Added 4.34%	77,108 Common Stock
Oct 02 2023	SELL Open market or private sale	$82,564 $27.24 p/Share	3,031 Reduced 3.95%	73,610 Common Stock
Oct 02 2023	BUY Exercise of conversion of derivative security	$9,153 $3.02 p/Share	3,031 Added 3.8%	76,641 Common Stock
Sep 19 2023	SELL Open market or private sale	$811,999 $32.48 p/Share	25,000 Reduced 25.35%	73,610 Common Stock
Sep 18 2023	BUY Exercise of conversion of derivative security	$75,500 $3.02 p/Share	25,000 Added 20.22%	98,610 Common Stock
Sep 01 2023	SELL Bona fide gift	-	1,059 Reduced 3.92%	25,929 Common Stock
Sep 01 2023	BUY Grant, award, or other acquisition	$15,093 $16.55 p/Share	912 Added 1.22%	73,610 Common Stock
Jul 17 2023	SELL Bona fide gift	-	10,000 Reduced 27.04%	26,988 Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$19,200 $1.92 p/Share	10,000 Added 12.09%	72,698 Common Stock
Jun 01 2023	SELL Bona fide gift	-	1,658 Reduced 4.29%	36,988 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	$38,100 $11.49 p/Share	3,316 Added 5.02%	62,698 Common Stock
Mar 01 2023	SELL Bona fide gift	-	1,460 Reduced 3.64%	38,646 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	$28,995 $9.93 p/Share	2,920 Added 4.69%	59,382 Common Stock
Dec 01 2022	SELL Open market or private sale	$15,800 $25.28 p/Share	625 Reduced 1.09%	56,462 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	$2,056 $3.29 p/Share	625 Added 1.08%	57,087 Common Stock
Nov 10 2022	SELL Open market or private sale	$639,250 $25.57 p/Share	25,000 Reduced 30.69%	56,462 Common Stock
Nov 10 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.48%	81,462 Common Stock
Oct 03 2022	SELL Open market or private sale	$641,000 $25.64 p/Share	25,000 Reduced 30.69%	56,462 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.48%	81,462 Common Stock
Sep 01 2022	SELL Bona fide gift	-	922 Reduced 2.25%	40,106 Common Stock
Sep 01 2022	SELL Open market or private sale	$646,000 $25.84 p/Share	25,000 Reduced 31.4%	54,618 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.9%	79,618 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	$23,954 $12.99 p/Share	1,844 Added 3.16%	56,462 Common Stock
Aug 19 2022	SELL Bona fide gift	-	14,594 Reduced 26.24%	41,028 Common Stock

Sean Maduck

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account